Intec Pharma Ltd (NASDAQ:NTEC)’s share price gapped up prior to trading on Monday . The stock had previously closed at $5.64, but opened at $5.72. Intec Pharma shares last traded at $5.83, with a volume of 50,068 shares changing hands.

Separately, Zacks Investment Research raised Intec Pharma from a “sell” rating to a “hold” rating in a research report on Wednesday, April 20th.

The stock’s market capitalization is $66.51 million. The firm has a 50 day moving average of $4.73 and a 200 day moving average of $4.16.

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.